NCT04010786View on ClinicalTrials.gov

A Research Study Investigating NNC0247-0829 for Weight Management in People With Overweight or Obesity

PHASE1CompletedINTERVENTIONAL
Enrollment

103

Participants

Timeline

Start Date

July 11, 2019

Primary Completion Date

June 11, 2022

Study Completion Date

June 21, 2022

Conditions
OverweightObesity
Interventions
DRUG

NNC0247-0829

Participants will receive either single or multiple doses given subcutaneously (s.c., under the skin) in a lifted fold of the stomach skin. Dose level and number of doses will depend on the cohort.

DRUG

Placebo (NNC0247-0829)

Participants will receive either single or multiple doses of placebo given s.c. in a lifted fold of the stomach skin.

Trial Locations (1)

78209

ICON Early Phase Services, LLC, San Antonio

Sponsors

Lead Sponsor

Novo Nordisk A/S
All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY

NCT04010786 - A Research Study Investigating NNC0247-0829 for Weight Management in People With Overweight or Obesity | Biotech Hunter | Biotech Hunter